Rapid CommunicationMinireview
Autophagy and Cancer Therapy
Andrew Thorburn, Douglas H. Thamm and Daniel L. Gustafson
Molecular Pharmacology June 2014, 85 (6) 830-838; DOI: https://doi.org/10.1124/mol.114.091850
Andrew Thorburn
Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado (A.T.); and Flint Animal Cancer Center, Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado (D.H.T., D.L.G.)
Douglas H. Thamm
Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado (A.T.); and Flint Animal Cancer Center, Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado (D.H.T., D.L.G.)
Daniel L. Gustafson
Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado (A.T.); and Flint Animal Cancer Center, Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado (D.H.T., D.L.G.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Rapid CommunicationMinireview
Autophagy and Cancer Therapy
Andrew Thorburn, Douglas H. Thamm and Daniel L. Gustafson
Molecular Pharmacology June 1, 2014, 85 (6) 830-838; DOI: https://doi.org/10.1124/mol.114.091850
Jump to section
- Article
- Abstract
- Introduction
- Cancer Therapy Effects on Autophagy: Inhibition and Activation
- Effects of Autophagy on Cancer Therapy: Both Positive and Negative
- Cell Autonomous and Nonautonomous Effects of Autophagy on Cancer Therapy
- Are We Using the Best Drugs to Inhibit Autophagy?
- How Will We Know If We Have Affected Autophagy in a Patient’s Tumor?
- Some Tumors Are More Dependent on Autophagy than Others
- Summary and Problems To Be Solved
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement